Spinal Cord Stimulation Versus Instrumentation for FBSS
- Conditions
- SCSFailed Back Surgery SyndromeNeuromodulationLow Back PainSpinal Cord StimulationSpinal Fusion
- Registration Number
- NCT05466110
- Lead Sponsor
- University Hospital Augsburg
- Brief Summary
Low back pain affects people of all ages and has become the leading cause of living with disability worldwide. Patients, suffering from persistent pain after spinal surgery in the absence of any clear spinal pathology are defined of having a "failed back surgery syndrome (FBSS)" and treatment of FBSS remains a great controversy in the spinal community. Apart from conservative treatment, spinal fusion remains as therapeutic option. Furthermore, minimal invasive Neuromodulation techniques might be a promising alternative. Aim of this randomized interventional multi center study is to compare treatment success in FBSS patients with either spinal cord stimulation (SCS) or fusion surgery, 12 months after intervention according to the Oswestry Disability Index (ODI) and other scales and scores. Radiological and health economic outcome also will be analysed for thorough comparison of techniques. Additionally, the safety of the interventions needs to be compared.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 84
- Age ≥18 years
- Symptomatic degenerative disc disease with LBP as a predominant symptom for at least 6 months following pervious surgery for disc herniation
- ODI score at least 21
- Correctly signed informed consent form
- Spinal stenosis resulting in spinal claudication or neurological deficits
- Spinal Instability (> 3 mm Motion on dynamic Lumbar X-rays)
- Major psychiatric disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Oswestry disability index / ODI 12 months after intervention A patient reported outcome measure to rate pain and disability
- Secondary Outcome Measures
Name Time Method Pain medication 12 months after intervention Amount of analgesics taken (drug, dose, mode of application)
hospital length of stay through study completion, an average of 2 years Time measured in days, counting from the first day of hospitalization until the day of discharge of the hospitalization the surgical intervention was performed. If surgery is performed as staged procedure in two separate hospitalizations (SCS) both hospitalizations are counted as described above and days are summed up.
Adverse events 12 months after intervention Comparison of complication rates
SF36 12 months after intervention Score to assess quality of life
EuroQOL 5D 12 months after intervention Score to assess quality of life
Crossover rates 12 months after intervention Rates of crossover to another therapy arm
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University Hospital Augsburg Department of Neurosurgery
🇩🇪Augsburg, Bavaria, Germany
University Hospital Augsburg Department of Neurosurgery🇩🇪Augsburg, Bavaria, GermanyEhab Shiban, MDContactEhab.shiban@uk-augsburg.dePhilipp Krauss, MDContactphilippemanuel.krauss@uk-augsburg.de